<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 39.96?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Database (Oxford)</journal-id>
    <journal-id journal-id-type="iso-abbrev">Database (Oxford)</journal-id>
    <journal-id journal-id-type="publisher-id">databa</journal-id>
    <journal-id journal-id-type="hwp">databa</journal-id>
    <journal-title-group>
      <journal-title>Database: The Journal of Biological Databases and Curation</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-0463</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">4494013</article-id>
    <article-id pub-id-type="doi">10.1093/database/bav067</article-id>
    <article-id pub-id-type="publisher-id">bav067</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>EpiFactors: a comprehensive database of human epigenetic factors and
complexes</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Medvedeva</surname>
          <given-names>Yulia A.</given-names>
        </name>
        <xref ref-type="aff" rid="bav067-AFF1">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="bav067-AFF2">
          <sup>2</sup>
        </xref>
        <xref ref-type="corresp" rid="bav067-COR1">*</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lennartsson</surname>
          <given-names>Andreas</given-names>
        </name>
        <xref ref-type="aff" rid="bav067-AFF3">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ehsani</surname>
          <given-names>Rezvan</given-names>
        </name>
        <xref ref-type="aff" rid="bav067-AFF4">
          <sup>4</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kulakovskiy</surname>
          <given-names>Ivan V.</given-names>
        </name>
        <xref ref-type="aff" rid="bav067-AFF2">
          <sup>2</sup>
        </xref>
        <xref ref-type="aff" rid="bav067-AFF5">
          <sup>5</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Vorontsov</surname>
          <given-names>Ilya E.</given-names>
        </name>
        <xref ref-type="aff" rid="bav067-AFF2">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Panahandeh</surname>
          <given-names>Pouda</given-names>
        </name>
        <xref ref-type="aff" rid="bav067-AFF4">
          <sup>4</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Khimulya</surname>
          <given-names>Grigory</given-names>
        </name>
        <xref ref-type="aff" rid="bav067-AFF2">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kasukawa</surname>
          <given-names>Takeya</given-names>
        </name>
        <xref ref-type="aff" rid="bav067-AFF6">
          <sup>6</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <collab>The FANTOM Consortium</collab>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Drabløs</surname>
          <given-names>Finn</given-names>
        </name>
        <xref ref-type="aff" rid="bav067-AFF4">
          <sup>4</sup>
        </xref>
        <xref ref-type="corresp" rid="bav067-COR2">*</xref>
      </contrib>
      <aff id="bav067-AFF1"><sup>1</sup>Institute of Personal and Predictive Medicine of
Cancer, 08916 Badalona, Spain,</aff>
      <aff id="bav067-AFF2"><sup>2</sup>Department of Computational Biology, Vavilov Institute
of General Genetics, Russian Academy of Sciences, 119991 Moscow, Russia,</aff>
      <aff id="bav067-AFF3"><sup>3</sup>Department of Biosciences and Nutrition, Karolinska
Institutet, 14183 Huddinge, Sweden,</aff>
      <aff id="bav067-AFF4"><sup>4</sup>Department of Cancer Research and Molecular Medicine,
Norwegian University of Science and Technology, NO-7489 Trondheim, Norway,</aff>
      <aff id="bav067-AFF5"><sup>5</sup>Engelhardt Institute of Molecular Biology, Russian
Academy of Sciences, 119991 Moscow, Russia,</aff>
      <aff id="bav067-AFF6"><sup>6</sup>Division of Genomic Technologies (DGT), RIKEN Center
for Life Science Technologies, 1-7-22 Suehiro-Cho, Tsurumi-Ku, Yokohama 230-0045,
Kanagawa, Japan</aff>
    </contrib-group>
    <author-notes>
      <corresp id="bav067-COR1">*Corresponding author: Tel: <phone>+34 935543072</phone>;
Fax: <fax>+93 4651472</fax>; Email:
<email>ju.medvedeva@gmail.com</email></corresp>
      <corresp id="bav067-COR2">Correspondence may also be addressed to Finn Drabløs.
Tel: <phone>+47 72573333</phone>; Fax: +<fax>47 72825736</fax>; Email:
<email>finn.drablos@ntnu.no</email></corresp>
      <fn id="FN100">
        <p>Citation details: Medvedeva,Y.A., Lennartsson,A., Ehsani,R., <italic>et
al</italic>. EpiFactors: a comprehensive database of human epigenetic factors
and complexes. <italic>Database</italic> (2015) Vol. 2015: article ID bav067;
doi:10.1093/database/bav067</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2015</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>07</day>
      <month>7</month>
      <year>2015</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>07</day>
      <month>7</month>
      <year>2015</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
    <volume>2015</volume>
    <elocation-id>bav067</elocation-id>
    <history>
      <date date-type="received">
        <day>24</day>
        <month>3</month>
        <year>2015</year>
      </date>
      <date date-type="rev-recd">
        <day>29</day>
        <month>5</month>
        <year>2015</year>
      </date>
      <date date-type="accepted">
        <day>15</day>
        <month>6</month>
        <year>2015</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2015. Published by Oxford University
Press.</copyright-statement>
      <copyright-year>2015</copyright-year>
      <license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits
unrestricted reuse, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
      </license>
    </permissions>
    <abstract>
      <p>Epigenetics refers to stable and long-term alterations of cellular traits that are
not caused by changes in the DNA sequence <italic>per se</italic>. Rather, covalent
modifications of DNA and histones affect gene expression and genome stability
<italic>via</italic> proteins that recognize and act upon such modifications. Many
enzymes that catalyse epigenetic modifications or are critical for enzymatic
complexes have been discovered, and this is encouraging investigators to study the
role of these proteins in diverse normal and pathological processes. Rapidly growing
knowledge in the area has resulted in the need for a resource that compiles,
organizes and presents curated information to the researchers in an easily accessible
and user-friendly form. Here we present EpiFactors, a manually curated database
providing information about epigenetic regulators, their complexes, targets and
products. EpiFactors contains information on 815 proteins, including 95 histones and
protamines. For 789 of these genes, we include expressions values across several
samples, in particular a collection of 458 human primary cell samples (for
approximately 200 cell types, in many cases from three individual donors), covering
most mammalian cell steady states, 255 different cancer cell lines (representing
approximately 150 cancer subtypes) and 134 human postmortem tissues. Expression
values were obtained by the FANTOM5 consortium using Cap Analysis of Gene Expression
technique. EpiFactors also contains information on 69 protein complexes that are
involved in epigenetic regulation. The resource is practical for a wide range of
users, including biologists, pharmacologists and clinicians.</p>
      <p><bold>Database URL</bold>: <ext-link ext-link-type="uri" xlink:href="http://epifactors.autosome.ru">http://epifactors.autosome.ru</ext-link></p>
    </abstract>
    <counts>
      <page-count count="10"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro">
    <title>Introduction</title>
    <p>Epigenetics has emerged as an extremely fast-growing area of biomedical research. The
term ‘epigenetics’ covers DNA and histone modifications, as well as
chromatin remodeling. DNA methylation, one of the key epigenetic mechanisms, is involved
in differentiation, pluripotency, aging, memory formation and responses to environmental
changes (<xref rid="bav067-B1" ref-type="bibr">1–5</xref>), and it is associated with repression of transcription when
present in promoters and expression activation when present in the gene bodies
(reviewed, for example, in Refs. (<xref rid="bav067-B6" ref-type="bibr">6</xref>,<xref rid="bav067-B7" ref-type="bibr">7</xref>)). At least three independent DNA
methyltransferases, DNMT1, DNMT3A and DNMT3B, can establish DNA methylation. The loss of
any of these proteins is lethal in mice (<xref rid="bav067-B8" ref-type="bibr">8</xref>). How DNA methylation affects transcription is still under debate (<xref rid="bav067-B9" ref-type="bibr">9–12</xref>).
Also, the mechanisms of active DNA demethylation are not completely understood. However,
several groups of proteins, such as ten-eleven translocation (TET) proteins and DNA
glycosylases have been shown to be involved (<xref rid="bav067-B13" ref-type="bibr">13</xref>). Also, at least two groups of proteins, methyl-binding domain proteins
(<xref rid="bav067-B14" ref-type="bibr">14</xref>) and CxxC proteins (<xref rid="bav067-B15" ref-type="bibr">15</xref>), can recognize the unmethylated or
methylated state of DNA and transmit signals to other regulatory proteins.</p>
    <p>Chromatin modification and remodeling are also vital epigenetic mechanisms. In
eukaryotes, the core chromatin structural unit—the nucleosome—is composed of
eight histones (two copies of H2A, H2B, H3 and H4) (<xref rid="bav067-B16" ref-type="bibr">16</xref>). The human genome encodes for more than 70 different
histone proteins, expressed differently depending upon the cellular and environmental
conditions. In human sperm most of the histones are replaced by protamines, which is
essential for the higher DNA condensation in sperm cells (<xref rid="bav067-B17" ref-type="bibr">17</xref>). Histones are subject to a large number of reversible
post-translational modifications. Such modifications can modulate chromatin structure,
and they can be recognized by specific proteins or protein domains. Such modifications
are crucial for epigenetic regulation of transcription, genome stability, DNA damage
response, X chromosome inactivation and formation of epigenetic memory (<xref rid="bav067-B18" ref-type="bibr">18–21</xref>). Various histone marks tend to co-occur in patterns, usually
referred to as the histone code (<xref rid="bav067-B22" ref-type="bibr">22</xref>),
which in turn can be ‘read’ by other proteins (<xref rid="bav067-B23" ref-type="bibr">23</xref>). So far dozens of genes are known to encode proteins that
establish or remove histone modifications in the human genome. Chromatin remodeling is
carried out by ATP-dependent complexes, which either move, eject or restructure
nucleosomes (<xref rid="bav067-B24" ref-type="bibr">24</xref>). Histone chaperones,
critical for nucleosome assembly following DNA replication, DNA repair and gene
transcription, also play an important role in epigenetic regulation (<xref rid="bav067-B25" ref-type="bibr">25</xref>).</p>
    <p>The definition of epigenetic factors is not trivial. In addition to the core epigenetic
proteins that initiate, modify and act upon epigenetic modifications as described
earlier, there are a range of borderline cases, in particular because these core
proteins are part of large networks of gene regulation and complex formation (i.e.
through protein–protein interactions). Such borderline cases may include
transcription factors (TFs) that regulate genes coding for epigenetic factors, TF-like
proteins that recruit epigenetic proteins to specific genomic regions, micro-RNAs that
act upon mRNAs for epigenetic proteins and long non-coding RNAs that are involved in
genome organization and gene regulation. Genes encoding those regulators can in turn be
regulated epigenetically or by specific TFs (<xref rid="bav067-B26" ref-type="bibr">26</xref>, <xref rid="bav067-B27" ref-type="bibr">27</xref>), enormously expanding
the regulatory network with no clear boundaries between epigenetic and non-epigenetic
regulation. Here we mainly focus on the core epigenetic proteins, but some of the
borderline cases also have to be included, in particular if they are part of protein
complexes that are important for epigenetic processes.</p>
    <p>There is an increasing awareness that we have to consider the cell as composed of
molecular complexes, each of which performs an independent, discrete biological function
(<xref rid="bav067-B28" ref-type="bibr">28</xref>). In line with this, it should be
emphasized that in particular chromatin remodeling is usually not performed by single
protein, but by a protein complex, which serves to activate its members or increase
their stability. Recent studies of epigenetic complexes have revealed a substantial
diversity of proteins that are involved. Most complexes that previously were considered
unique appeared to be members of large complex families, as other proteins from the same
family could replace core subunits of the complex. There are several families of
well-studied epigenetic complexes in eukaryotes, such as SWI/SNF, ISWI, NuRD, INO80 and
PcG. To make the picture even more complicated, some proteins can participate in
formation of a variety of different complexes.</p>
    <p>Over the past decade, tremendous efforts have been directed towards understanding the
epigenetic regulatory mechanisms. It is worth noting that deregulation of epigenetic
processes is observed in many complex human diseases, including cancer,
neurodegenerative diseases and diabetes (<xref rid="bav067-B29" ref-type="bibr">29–31</xref>). Lately,
chromatin-modifying proteins have been considered as promising drug targets (<xref rid="bav067-B32" ref-type="bibr">32</xref>). Therefore, the information about
epigenetic regulators and their complexes is extremely relevant, not only for
understanding fundamental biological processes but also for understanding human
disorders. This makes a curated and structured source of such information beneficial not
only for biologists but also for clinicians. Currently, several publically available
databases provide information on the topic. Below we present a brief overview of
them.</p>
    <p>Databases on DNA methylation, such as MethDB (<xref rid="bav067-B33" ref-type="bibr">33</xref>, <xref rid="bav067-B34" ref-type="bibr">34</xref>), NGSmethDB (<xref rid="bav067-B35" ref-type="bibr">35</xref>), MethBank (<xref rid="bav067-B36" ref-type="bibr">36</xref>), MethylomeDB (<xref rid="bav067-B36" ref-type="bibr">36</xref>), MethHC (<xref rid="bav067-B37" ref-type="bibr">37</xref>), MethyCancer
(<xref rid="bav067-B38" ref-type="bibr">38</xref>) and The Cancer Genome Atlas (TCGA)
(<xref rid="bav067-B39" ref-type="bibr">39</xref>), primarily provide information
about methylation patterns in various normal and pathological conditions, obtained by
different experimental techniques. Yet, detailed information about proteins establishing
DNA methylation or performing active DNA demethylation, in particular in combination
with relevant expression data in various cells, is missing.</p>
    <p>Histones and their modifications in humans (mammals) are partially addressed in Human
Histone Modification Database (HHMD) (<xref rid="bav067-B40" ref-type="bibr">40</xref>),
Histone Database (<xref rid="bav067-B41" ref-type="bibr">41</xref>) and HIstome (<xref rid="bav067-B42" ref-type="bibr">42</xref>). The HHMD focuses on integration of
experimental data on genomic distributions of histone modifications. Therefore the
number of modifications covered is limited by the number of available antibodies.
Moreover, according to the web site, the last update of the database was published 3
years ago, which makes the information somewhat outdated. Histone Database (<xref rid="bav067-B41" ref-type="bibr">41</xref>) has an evolutionary focus collecting data
on histones in a large number of organisms including human. Yet, data on
histone-modifying enzymes are not integrated. The recently developed HIstome database
(<xref rid="bav067-B42" ref-type="bibr">42</xref>) compensates for this disadvantage
and combines information on the histone proteins and the histone-modifying enzymes.
However, other categories of epigenetic regulators are not covered.</p>
    <p>Over the last several years, there has been an increased recognition of the role of
chromatin remodelers. As a result, databases with a broader scope have started to
appear. Those databases incorporate not only information on histones and
histone-modifying enzymes but also include other proteins affecting the chromatin
structure without direct histone modifications. Among such databases are ChromDB (<xref rid="bav067-B43" ref-type="bibr">43</xref>), CREMOFAC (<xref rid="bav067-B44" ref-type="bibr">44</xref>) and CR Cistrome (<xref rid="bav067-B45" ref-type="bibr">45</xref>). ChromDB (<xref rid="bav067-B43" ref-type="bibr">43</xref>), which
provides information on chromatin-associated proteins for a broad range of organisms,
focuses on extremely well-studied plant genes encoding chromatin remodelers. CREMOFAC
(<xref rid="bav067-B44" ref-type="bibr">44</xref>) focuses on ATP-dependent and
-independent chromatin-remodeling factors with reduced information on histone-modifying
enzymes. CR Cistrome (<xref rid="bav067-B45" ref-type="bibr">45</xref>) contains
information about both chromatin remodelers and histone-modifying enzymes, but with a
primary focus on their interactions based on experimental data (ChIP-Seq) in human and
mouse. Although these databases represent a significant step toward a comprehensive
epigenetic knowledge base, each of them is still missing some important classes of
epigenetic regulators.</p>
    <p>Some databases go one step further and try to integrate information on various
epigenetic regulators. Among them is PEpiD (<xref rid="bav067-B46" ref-type="bibr">46</xref>), an epigenetic database that combines the three extensively characterized
epigenetic mechanisms (DNA methylation, histone modification and microRNA), implicated
in prostate cancer of human, mouse and rat. Also EPITRANS (<xref rid="bav067-B47" ref-type="bibr">47</xref>) and TCGA (<xref rid="bav067-B39" ref-type="bibr">39</xref>) should be mentioned, as they integrate epigenome and transcriptome data.
Furthermore, there are several databases that incorporate all sorts of epigenetic
information, such as the NCBI Epigenomics resource (<xref rid="bav067-B48" ref-type="bibr">48</xref>, <xref rid="bav067-B49" ref-type="bibr">49</xref>), NIH
Roadmap Epigenomics Program data resource (<xref rid="bav067-B50" ref-type="bibr">50</xref>) or ENCODE (<xref rid="bav067-B27" ref-type="bibr">27</xref>). Although
such resources provide enormous possibilities for exploring epigenomic data sets, they
are mainly focused on the genomic distribution of epigenetic modifications.</p>
    <p>Traditionally, the information about protein interactions is reported in a form of
one-to-one interactions [protein–protein interactions (PPIs)]. There are several
databases providing users with thousands of PPIs, usually with no distinction between
stable (long-time, complex forming) and transient (short-time, reversible and
context-dependent) interactions. Yet, recently the focus has changed, and the Complex
Portal (<xref rid="bav067-B51" ref-type="bibr">51</xref>), a complex-based database of
protein interactions is now part of the IntAct (<xref rid="bav067-B52" ref-type="bibr">52</xref>) molecular interaction database. Through Complex Portal protein complexes
from model organisms are available to search, view and download. But although complexes
in the database are annotated with details about their function, the Complex Portal does
not focus on epigenetically related complexes, and therefore information about such
complexes is difficult to extract.</p>
    <p>Despite the availability of existing resources on epigenetic regulation, there is still
a need for a comprehensive database that provides a compilation of functional
information about epigenetic regulators and their expression in multiple cell types. In
addition, since the role and diversity of epigenetic complexes now is recognized,
interactions between epigenetic regulators resulting in formation of stable epigenetic
complexes have to be included. Most importantly, comprehensive functional annotation is
needed to cover all possible epigenetic functions. To this end, we present EpiFactors; a
database encompassing detailed and curated information about 815 proteins and 69
complexes involved in epigenetic regulation. To the best of our knowledge, such ample
compilation of information on epigenetic factors is not available in any other public
resources.</p>
  </sec>
  <sec>
    <title>Database content and development</title>
    <p>To create a complete database of the epigenetic regulators, a decision has to be made on
which genes and proteins to include. For this purpose we developed a definition of
epigenetic factors. Such definitions are always arbitrary to some extent, although we
believe that our definition covers the majority of the genes and proteins involved in
epigenetic regulation.</p>
    <sec>
      <title>EpiFactors definitions</title>
      <p>We defined epigenetic factors as <list list-type="bullet"><list-item><p>Proteins acting as histones, histone variants or protamines;</p></list-item><list-item><p>Proteins performing post-translational modifications of histones or
recognizing such modifications (histone modification ‘writers’,
‘erasers’ or ‘readers’);</p></list-item><list-item><p>Proteins changing the general structure of chromatin (performing chromatin
remodeling), including <list list-type="bullet"><list-item><p>Proteins that move, eject or restructure nucleosomes (ATP-dependent
chromatin remodelers);</p></list-item><list-item><p>Proteins that incorporate histone variants into the
nucleosomes.</p></list-item></list></p></list-item><list-item><p>Proteins assisting histone folding and assembly;</p></list-item><list-item><p>Proteins acting upon modifications of DNA or RNA in such a way that it
affects gene expression, but not through RNA processing;</p></list-item><list-item><p>Protein cofactors forming complexes with epigenetic factors, where complex
formation is important for the activity.</p></list-item></list></p>
    </sec>
    <sec>
      <title>Epigenetic complexes</title>
      <p>As a starting point, we used the UniProt definition of protein complexes as provided
in the ‘function’ field for histone-modifying enzymes and
chromatin-remodeling proteins. Unfortunately, many of the techniques used to isolate
proteins are essentially disruptive to large protein complexes, and even worse,
various popular techniques are disruptive to a different extent, which leads to a
disagreement between studies with respect to whether some proteins are stable members
of a complex or just demonstrating transient PPIs. Although we could not fully
overcome this issue, we used information from the most recent papers and expert
opinions to exclude transient interactions and to correct the sets of proteins from
each complex accordingly. To specify members of the PCG1 complex family, we used the
classification provided by Gao <italic>et al.</italic> (<xref rid="bav067-B53" ref-type="bibr">53</xref>). Some histone-modifying and chromatin-remodeling
complexes were updated according to Schuettengruber <italic>et al.</italic> (<xref rid="bav067-B54" ref-type="bibr">54</xref>). To improve annotation of all
repressive complexes, we used a comprehensive review by Laugesen and Helin (<xref rid="bav067-B55" ref-type="bibr">55</xref>). A complete list of references is
linked to the relevant records of the database.</p>
      <p>Recent findings suggest that the borders separating protein complexes are becoming
vague (<xref rid="bav067-B56" ref-type="bibr">56</xref>), making definition of the
complexes even more complicated. In that line, we tried to group epigenetic
complexes, and therefore the complexes are structured into 19 functional complex
families.</p>
    </sec>
    <sec>
      <title>Data sources</title>
      <p>To create EpiFactors we merged the most recent and complete sets of genes related to
epigenetics from several sources, including the Histone Infobase (<xref rid="bav067-B42" ref-type="bibr">42</xref>) and selected relevant research papers
and reviews (<xref rid="bav067-B57" ref-type="bibr">57–60</xref>). Data from text mining using MeSHOP (MeSH Over-representation
Profiles) was also included (W. Wasserman, personal communication). We searched the
UniProt database for histones, protamines, their modifying enzymes, DNA methylation
enzymes, and chromatin-remodeling proteins in ‘reviewed’ entries of
UniProt using the keywords ‘histone’, ‘protamine’,
‘chromatin’ and ‘methylation’, with ‘human’ as
species. We manually extracted information about protein complexes from the
‘function’ field of the histone and DNA-modifying enzymes descriptions,
and then searched for other proteins in such complexes using the name of the complex
as a keyword in the ‘reviewed’ entries of UniProt. We also searched for
and investigated paralogs of all identified proteins. However, only proteins where
the role as an epigenetic factor was supported by literature were actually included
in EpiFactors. We curated the obtained entries to remove non-specific proteins and
add missing ones based on the literature. Through this exhaustive database and
literature search we identified 95 histones and histone variants (including
protamines), 720 DNA/RNA, histone and chromatin-modifying enzymes and their
cofactors, and 69 epigenetically relevant complexes. Publications have been used to
check the information on every single protein entry, its function, targets and
products (if applicable), and complexes that a protein could be involved in. The
database provides 598 unique PubMed references to support the annotation of proteins
and complexes.</p>
    </sec>
    <sec>
      <title>Functional classes annotation</title>
      <p>An important aspect of the database is to provide a useful and comprehensive
functional annotation of epigenetic factors. Such annotation is often implemented by
using standard gene ontology (GO), which has a rich vocabulary for describing protein
function. However, in this case we wanted a smaller set of terms that is more
directly targeted toward key aspects of epigenetics. We therefore developed the
following annotation scheme.</p>
      <sec>
        <title>General layout:</title>
        <p>
          <list list-type="order">
            <list-item>
              <p>Function [optional | terms] <list list-type="simple"><list-item><p>1.1. Modification (alternative | terms)</p></list-item><list-item><p>1.2. Modification</p></list-item><list-item><p>1.3. ...</p></list-item></list></p>
            </list-item>
          </list>
        </p>
      </sec>
      <sec>
        <title>Terms that may be used:</title>
        <p>
          <list list-type="order">
            <list-item>
              <p>DNA modification [cofactor] <list list-type="simple"><list-item><p>1.1. DNA (methylation | demethylation |
hydroxymethylation |…)</p></list-item></list></p>
            </list-item>
            <list-item>
              <p>RNA modification [cofactor] <list list-type="simple"><list-item><p>2.1. RNA (phosphorylation | deamination | degradation
|…)</p></list-item><list-item><p>2.2. mRNA editing</p></list-item></list></p>
            </list-item>
            <list-item>
              <p>Chromatin remodeling [cofactor]</p>
            </list-item>
            <list-item>
              <p>Histone chaperone [cofactor]</p>
            </list-item>
            <list-item>
              <p>Histone modification [read | write | erase] [cofactor] <list list-type="simple"><list-item><p>5.1. Histone (methylation | acetylation |
phosphorylation | ubiquitination | sumoylation |
GlcNAcylation | citrullination |…)</p></list-item></list></p>
            </list-item>
            <list-item>
              <p>Polycomb group (PcG) protein</p>
            </list-item>
            <list-item>
              <p>Scaffold protein</p>
            </list-item>
            <list-item>
              <p>TF <list list-type="simple"><list-item><p>8.1. TF (activator | repressor)</p></list-item></list></p>
            </list-item>
          </list>
        </p>
        <p>We included TFs only if they have been explicitly shown to have epigenetic
function, for example as essential members of histone-modifying complexes.</p>
      </sec>
    </sec>
    <sec>
      <title>Target molecules, targets and product annotation</title>
      <p>We also annotated entries (proteins and complexes) with information about targets, if
such information was available. We provided three types of target/product
annotations, covering molecule, target and product. The molecule may be either
chromatin, histone, DNA, RNA or mRNA. The target corresponds to the particular
nucleotide or amino acid that is affected. For example, C for DNA or H3K4 for
histone. Product annotation provides the output of the reaction, as detailed as
possible. This could be, for example, H3K4me or H3K4me3.</p>
    </sec>
    <sec>
      <title>Data processing, integration and links to external resources</title>
      <p>Custom scripts were used to parse UniProt, HGNC, Entrez, MGI and Pfam databases. In
addition to the annotation mentioned earlier, we provide external links to UniProt,
HGNC, Entrez, MGI, Pfam, FANTOM5 SSTAR (Abugessaisa <italic>et al</italic>. in
preparation), and other public databases. FANTOM5 SSTAR provides a way to explore
cell samples, sites of transcriptional initiation and regulators analysed in the
FANTOM5 project (<xref rid="bav067-B61" ref-type="bibr">61</xref>). Links to the
corresponding entry (cell type or gene) of FANTOM5 SSTAR are available from both
genes (<italic>via</italic> EntrezID) and expression pages. It is worth noting that
some epigenetic factors are also TFs and therefore can bind DNA in a
sequence-specific manner. If such sequence preferences are known we provide an
external link to a corresponding entry of the HOCOMOCO database, which contains
curated models of sequence-specific transcriptional factor binding sites (TFBS)
(<xref rid="bav067-B62" ref-type="bibr">62</xref>).</p>
    </sec>
    <sec>
      <title>Information on proteins/genes</title>
      <p>The protein page (for each EpiFactor gene or histone) provides a summary of all
available information about the protein and expression profiles of the corresponding
gene obtained by Cap Analysis of Gene Expression (CAGE), in particular for 458 human
primary cell samples, 255 different cancer cell lines and 134 human post-mortem
tissues (<xref rid="bav067-B61" ref-type="bibr">61</xref>). Expression values are
sorted and pre-filtered to have expression higher than 10 TPM (CAGE tags per million,
relative log expression normalization), but this threshold can be dynamically
adjusted. The quantile rank of the gene among all EpiFactors in a given sample is
also provided. The information on the gene expression can also be obtained on a per
sample basis through the ‘Expression’ tab. It shows all genes expressed
in a particular sample. For each gene we also provide quantile ranks of the gene
expression in this sample relatively to all other samples.</p>
      <p>For the majority of the proteins the respective mouse ortholog from MGI is provided.
Where possible we annotated proteins with functional class/function, complex and
target molecule/product (see categories above). We extracted such annotation from
relevant publications, and the PubMed ID (PMID) is given in the corresponding
field.</p>
    </sec>
    <sec>
      <title>Information on complexes</title>
      <p>The complex page provides information on important complexes in epigenetics,
including proteins involved in complex formation, the molecular and specific targets
and products, as well as relevant PMID references supporting the information. It is
worth noting that essential and variable members of the complex (according to UniProt
annotation) are marked in different colors.</p>
    </sec>
    <sec>
      <title>Implementation, web interface and visualization</title>
      <p>EpiFactors is available online <italic>via</italic> a user-friendly web interface
implemented as a Ruby-on-Rails front-end with an SQLite back-end. The home page
provides a graphical representation of epigenetic processes with all major elements
being ‘clickable’ and linked to the corresponding complex groups (<xref ref-type="fig" rid="bav067-F1">Figure 1</xref>). The content of the database can
also be accessed through four specific tables: ‘Genes’,
‘Complexes’, ‘Histones and protamines’,
‘Expression’, either directly or by using keyword search. Each data table
contains a customizable set of columns presenting information on respective entities.
A user can also browse individual histones, protamines, epigenetic modifiers and
their complexes. We also provide some general information in a ‘Docs’
section of the website, to explain the resource structure and how it can be used.
<fig id="bav067-F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Interactive navigation figure for web page. Names of the histones and
complexes are linked to the corresponding entities of the database. Since
complexes are represented by a group name, all complexes of the group will
be shown when the complex name is clicked on the website navigation figure.
Complexes are located in the area corresponding to the shown function. For
example CAF-1 (in lower right corner) participates in nucleosome assembly
after replication. </p></caption><graphic xlink:href="bav067f1p"/></fig>
</p>
    </sec>
    <sec>
      <title>Downloads</title>
      <p>All tables from the EpiFactors database can be downloaded in csv format. The
downloaded file contains all rows and columns that are currently visible, as well as
corresponding external links to facilitate downstream analysis. For a particular
gene, the expression data can also be downloaded in csv format for all samples where
the expression level of the gene is above a selected threshold. Also, expression
tables of all the epigenetic factors in all samples can be downloaded from the
Download section of the database.</p>
    </sec>
    <sec>
      <title>Summary statistics</title>
      <p>The content of the EpiFactors database can be described through some summary
statistics. <xref ref-type="table" rid="bav067-T1">Table 1</xref> shows the number of
proteins that have been annotated with each of the main terms for function, and for
the type of modification that is targeted (counted across all functions). Please note
that some proteins can be annotated with more than one function. The most frequent
functions are writing and reading histone modifications, and chromatin remodeling.
The most frequent targets are not only, in particular, methylations and acetylations,
but also phosphorylations and ubiquitinations. <table-wrap id="bav067-T1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Frequency of main terms in annotation</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Function</th><th rowspan="1" colspan="1">Count</th><th rowspan="1" colspan="1">Modification</th><th rowspan="1" colspan="1">Count</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">DNA modification</td><td align="char" char="." rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">DNA methylation</td><td align="char" char="." rowspan="1" colspan="1">7</td></tr><tr><td rowspan="1" colspan="1">RNA modification</td><td align="char" char="." rowspan="1" colspan="1">30</td><td rowspan="1" colspan="1">DNA demethylation</td><td align="char" char="." rowspan="1" colspan="1">12</td></tr><tr><td rowspan="1" colspan="1">Chromatin remodeling</td><td align="char" char="." rowspan="1" colspan="1">101</td><td rowspan="1" colspan="1">DNA hydroxymethylation</td><td align="char" char="." rowspan="1" colspan="1">5</td></tr><tr><td rowspan="1" colspan="1">Chromatin remodeling cofactor</td><td align="char" char="." rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">RNA degradation</td><td align="char" char="." rowspan="1" colspan="1">9</td></tr><tr><td rowspan="1" colspan="1">Histone chaperone</td><td align="char" char="." rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">mRNA editing</td><td align="char" char="." rowspan="1" colspan="1">10</td></tr><tr><td rowspan="1" colspan="1">Histone modification</td><td align="char" char="." rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">Histone methylation</td><td align="char" char="." rowspan="1" colspan="1">127</td></tr><tr><td rowspan="1" colspan="1">Histone modification cofactor</td><td align="char" char="." rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">Histone acetylation</td><td align="char" char="." rowspan="1" colspan="1">139</td></tr><tr><td rowspan="1" colspan="1">Histone modification read</td><td align="char" char="." rowspan="1" colspan="1">90</td><td rowspan="1" colspan="1">Histone phosphorylation</td><td align="char" char="." rowspan="1" colspan="1">55</td></tr><tr><td rowspan="1" colspan="1">Histone modification write</td><td align="char" char="." rowspan="1" colspan="1">158</td><td rowspan="1" colspan="1">Histone ubiquitination</td><td align="char" char="." rowspan="1" colspan="1">61</td></tr><tr><td rowspan="1" colspan="1">Histone modification write cofactor</td><td align="char" char="." rowspan="1" colspan="1">95</td><td rowspan="1" colspan="1">Histone sumoylation</td><td align="char" char="." rowspan="1" colspan="1">2</td></tr><tr><td rowspan="1" colspan="1">Histone modification erase</td><td align="char" char="." rowspan="1" colspan="1">66</td><td rowspan="1" colspan="1">Histone citrullination</td><td align="char" char="." rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1">Histone modification erase cofactor</td><td align="char" char="." rowspan="1" colspan="1">58</td><td rowspan="1" colspan="1">TF activator</td><td align="char" char="." rowspan="1" colspan="1">18</td></tr><tr><td rowspan="1" colspan="1">Polycomb group (PcG) protein</td><td align="char" char="." rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">TF repressor</td><td align="char" char="." rowspan="1" colspan="1">27</td></tr><tr><td rowspan="1" colspan="1">Scaffold protein</td><td align="char" char="." rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">TF</td><td align="char" char="." rowspan="1" colspan="1">53</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></p>
      <p><xref ref-type="fig" rid="bav067-F2">Figure 2</xref> shows the most frequent Pfam
domains in EpiFactors. Several of these domains are known to be strongly associated
with epigenetic processes (see later). <fig id="bav067-F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>The most frequently occurring Pfam domains in EpiFactors. Multiple
occurrences of a domain within the same protein are counted as one
occurrence.</p></caption><graphic xlink:href="bav067f2p"/></fig>
</p>
      <p><xref ref-type="table" rid="bav067-T2">Table 2</xref> shows the most significantly
enriched Pfam domains. It shows domains that are enriched in EpiFactors relative to a
background of 20 200 reviewed human UniProt entries (left part of table). It
also shows domains that are enriched for specific functions within EpiFactors,
relative to the whole EpiFactors database (right part of table). These two tests for
enrichment are independent, but are shown in a joint table because domains that are
significantly enriched within EpiFactors (e.g. the SET domain) also tend to be
enriched with respect to a specific function (e.g. writing a histone methylation).
All enrichments are significant at <italic>P</italic>&lt;0.05 according to a
Fisher’s exact test after Bonferroni correction (not shown), except for Chromo,
PHD and PWWP with respect to Function (right part). <table-wrap id="bav067-T2" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Significantly enriched Pfam domains</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="2" colspan="1">Pfam domain</th><th colspan="2" rowspan="1">EpiFactors<hr/></th><th rowspan="2" colspan="1">EpiFactors function; modification</th><th colspan="2" rowspan="1">Function<hr/></th></tr><tr><th rowspan="1" colspan="1">In</th><th rowspan="1" colspan="1">Out</th><th rowspan="1" colspan="1">In</th><th rowspan="1" colspan="1">Out</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">SET</td><td align="char" char="." rowspan="1" colspan="1">36</td><td align="char" char="." rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">Histone modification write; Histone methylation</td><td align="char" char="." rowspan="1" colspan="1">33</td><td align="char" char="." rowspan="1" colspan="1">3</td></tr><tr><td rowspan="1" colspan="1">JmjC</td><td align="char" char="." rowspan="1" colspan="1">22</td><td align="char" char="." rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">Histone modification erase; Histone methylation</td><td align="char" char="." rowspan="1" colspan="1">21</td><td align="char" char="." rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">JmjN</td><td align="char" char="." rowspan="1" colspan="1">10</td><td align="char" char="." rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">Histone modification erase; Histone methylation</td><td align="char" char="." rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">Hist_deacetyl</td><td align="char" char="." rowspan="1" colspan="1">11</td><td align="char" char="." rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">Histone modification erase; Histone acetylation</td><td align="char" char="." rowspan="1" colspan="1">11</td><td align="char" char="." rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">SNF2_N</td><td align="char" char="." rowspan="1" colspan="1">28</td><td align="char" char="." rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">Chromatin remodeling</td><td align="char" char="." rowspan="1" colspan="1">25</td><td align="char" char="." rowspan="1" colspan="1">3</td></tr><tr><td rowspan="1" colspan="1">Bromodomain</td><td align="char" char="." rowspan="1" colspan="1">36</td><td align="char" char="." rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">Histone modification</td><td align="char" char="." rowspan="1" colspan="1">33</td><td align="char" char="." rowspan="1" colspan="1">3</td></tr><tr><td rowspan="1" colspan="1">zf-HC5HC2H_2</td><td align="char" char="." rowspan="1" colspan="1">12</td><td align="char" char="." rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">Histone modification; Histone methylation</td><td align="char" char="." rowspan="1" colspan="1">12</td><td align="char" char="." rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">Chromo</td><td align="char" char="." rowspan="1" colspan="1">26</td><td align="char" char="." rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">Histone modification read</td><td align="char" char="." rowspan="1" colspan="1">10</td><td align="char" char="." rowspan="1" colspan="1">16</td></tr><tr><td rowspan="1" colspan="1">PHD</td><td align="char" char="." rowspan="1" colspan="1">55</td><td align="char" char="." rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">Histone modification read; Histone methylation</td><td align="char" char="." rowspan="1" colspan="1">17</td><td align="char" char="." rowspan="1" colspan="1">38</td></tr><tr><td rowspan="1" colspan="1">PWWP</td><td align="char" char="." rowspan="1" colspan="1">16</td><td align="char" char="." rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">Histone modification read</td><td align="char" char="." rowspan="1" colspan="1">7</td><td align="char" char="." rowspan="1" colspan="1">9</td></tr></tbody></table><table-wrap-foot><fn id="bav067-TF1"><p>In and Out for EpiFactors (left part of table) represents the number of
occurrences that are inside and outside the list of EpiFactors (the
‘outside’ set corresponds to 20 200 reviewed human
UniProt entries, minus the EpiFactors entries). In and Out for Function
(right part) represents the number of occurrences of the same Pfam domain
that are found inside and outside of that particular term in EpiFactors.
All enrichments are statistically significant according to a
Fisher’s exact test, also after correction for multiple testing,
except for the Chromo, PHD and PWWP domains with respect to Function
(right part).</p></fn></table-wrap-foot></table-wrap></p>
      <p>For each case in <xref ref-type="table" rid="bav067-T2">Table 2</xref> we show the
number of entries that are inside the set (e.g. in the EpiFactors database) or
outside (e.g. in the reviewed UniProt entries not included in EpiFactors). The
numbers for inclusion in EpiFactors (left part) show that almost all proteins with
the domains listed here are included. We should stress that this information was
normally not used when selecting proteins for EpiFactors, which was based almost
exclusively on literature data. However, the numbers indicate that we have achieved a
good coverage of some important Pfam domains. We see a similar trend for the
annotation of Function within EpiFactors (right part), indicating good quality of
this annotation. The main exceptions are the Chromo, PHD and PWWP domains, where only
subsets of proteins with these domains are associated with specific functions.</p>
      <p>The domains listed in <xref ref-type="table" rid="bav067-T2">Table 2</xref> are
mainly as expected. For example, the SET domain is known to be involved in histone
methylation (<xref rid="bav067-B63" ref-type="bibr">63</xref>), the Jmj (Jumonji)
domain in histone demethylation (<xref rid="bav067-B64" ref-type="bibr">64</xref>),
the Hist_deacetyl domain in histone deacetylation and the SNF2 domain in chromatin
remodeling (<xref rid="bav067-B65" ref-type="bibr">65</xref>).</p>
    </sec>
  </sec>
  <sec>
    <title>EpiFactors summary</title>
    <p>EpiFactors is a web-accessible database that provides broad information about human
proteins and complexes involved in epigenetic regulation. It also lists corresponding
genes and their expression levels in several samples, in particular 458 human primary
cell samples, 255 different cancer cell lines and 134 human post-mortem tissues. Each
protein and complex entry has been provided with links to external public resources. We
believe that the database will be a valuable tool for researchers working in the rapidly
growing field of epigenetics.</p>
  </sec>
  <sec>
    <title>Future developments</title>
    <p>The database content is carefully maintained and updated. Repeated literature searches
are planned to allow for identification and integration of new entries into the database
on a regular basis. A module on association of epigenetic factors with pathological
conditions has been planned during expansion phase. We will also consider inclusion of
data for other model organisms, to broaden the scope of the database to a larger
audience. Any input from groups and individuals with specific areas of epigenetic
expertise is welcome.</p>
  </sec>
</body>
<back>
  <ack>
    <title>Acknowledgements</title>
    <p>The authors are grateful to Anna Palau for her help with the Polycomb group complexes,
to Darya Dementieva for her help with the main web-page graphics and to Wyeth Wasserman
for gene lists based on MeSHOP text mining.</p>
  </ack>
  <sec>
    <title>Funding</title>
    <p>This work was supported by <funding-source>Russian Fund For Basic Research
(RFFI)</funding-source>, grant <award-id>14-04-00180</award-id> to Y.A.M. and,
partially, by grant <award-id>15-34-20423</award-id> mol_a_ved to I.V.K.; Y.A.M. was
supported by the fellowship FPDI-2013-18088 from <funding-source>Ministerio de Economia
Y Competividad, Spain</funding-source> and by the grant
<award-id>BFU2011-30246</award-id> from Ministerio de Economia Y Competividad, Spain;
A.L. was supported by Åke Olsson’s foundation, the <funding-source>Swedish
Cancer foundation</funding-source> and the <funding-source>Swedish Childhood
cancer</funding-source> foundation; I.V.K. was personally supported by the
<funding-source>Dynasty Foundation Fellowship</funding-source>;
<award-id>FANTOM5</award-id> was made possible by a Research Grant for RIKEN Omics
Science Center from the Japanese Ministry of Education, Culture, Sports, Science and
Technology (MEXT) to Yoshihide Hayashizaki, Grant from MEXT for the RIKEN Preventive
Medicine and Diagnosis Innovation Program to Yoshihide Hayashizaki, Grant of the
Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the
MEXT, Japan to Yoshihide Hayashizaki and Grant from MEXT to the RIKEN Center for Life
Science Technologies. We thank all members of the FANTOM5 consortium for
contributing to generation of samples and analysis of the data set and thank GeNAS for
data production. Funding for open access publication has been provided by the Norwegian
University of Science and Technology (NTNU).</p>
    <p><italic>Conflict of interest.</italic> None declared.</p>
  </sec>
  <ref-list>
    <title>References</title>
    <ref id="bav067-B1">
      <label>1</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jirtle</surname><given-names>R.L.</given-names></name><name><surname>Skinner</surname><given-names>M.K.</given-names></name></person-group> (<year>2007</year>) <article-title>Environmental
epigenomics and disease susceptibility</article-title>. <source>Nat. Rev.
Genet.</source>, <volume>8</volume>,
<fpage>253</fpage>–<lpage>262</lpage>.<pub-id pub-id-type="pmid">17363974</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B2">
      <label>2</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rakyan</surname><given-names>V.K.</given-names></name><name><surname>Down</surname><given-names>T.A.</given-names></name><name><surname>Maslau</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2010</year>) <article-title>Human
aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin
domains</article-title>. <source>Genome Res.</source>, <volume>20</volume>,
<fpage>434</fpage>–<lpage>439</lpage>.<pub-id pub-id-type="pmid">20219945</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B3">
      <label>3</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaenisch</surname><given-names>R.</given-names></name><name><surname>Bird</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>) <article-title>Epigenetic regulation of
gene expression: how the genome integrates intrinsic and environmental
signals</article-title>. <source>Nat. Genet.</source>, <comment>33 Suppl,
245–254</comment>.</mixed-citation>
    </ref>
    <ref id="bav067-B4">
      <label>4</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomazou</surname><given-names>E.M.</given-names></name><name><surname>Meissner</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>) <article-title>Epigenetic regulation of
pluripotency</article-title>. <source>Adv. Exp. Med. Biol</source>.,
<volume>695</volume>, <fpage>26</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">21222197</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B5">
      <label>5</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>C.A.</given-names></name><name><surname>Sweatt</surname><given-names>J.D.</given-names></name></person-group> (<year>2007</year>) <article-title>Covalent modification of
DNA regulates memory formation</article-title>. <source>Neuron</source>,
<volume>53</volume>, <fpage>857</fpage>–<lpage>869</lpage>.<pub-id pub-id-type="pmid">17359920</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B6">
      <label>6</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>P.A.</given-names></name><name><surname>Takai</surname><given-names>D.</given-names></name></person-group> (<year>2001</year>) <article-title>The role of DNA
methylation in mammalian epigenetics</article-title>. <source>Science</source>,
<volume>293</volume>,
<fpage>1068</fpage>–<lpage>1070</lpage>.<pub-id pub-id-type="pmid">11498573</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B7">
      <label>7</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schubeler</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>) <article-title>Function and information
content of DNA methylation</article-title>. <source>Nature</source>,
<volume>517</volume>,
<fpage>321</fpage>–<lpage>326</lpage>.<pub-id pub-id-type="pmid">25592537</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B8">
      <label>8</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>E.</given-names></name><name><surname>Bestor</surname><given-names>T.H.</given-names></name><name><surname>Jaenisch</surname><given-names>R.</given-names></name></person-group> (<year>1992</year>) <article-title>Targeted mutation of the
DNA methyltransferase gene results in embryonic lethality</article-title>.
<source>Cell</source>, <volume>69</volume>,
<fpage>915</fpage>–<lpage>926</lpage>.<pub-id pub-id-type="pmid">1606615</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B9">
      <label>9</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lienert</surname><given-names>F.</given-names></name><name><surname>Wirbelauer</surname><given-names>C.</given-names></name><name><surname>Som</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2011</year>) <article-title>Identification
of genetic elements that autonomously determine DNA methylation
states</article-title>. <source>Nat. Genet.</source>, <volume>43</volume>,
<fpage>1091</fpage>–<lpage>1097</lpage>.<pub-id pub-id-type="pmid">21964573</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B10">
      <label>10</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choy</surname><given-names>M.K.</given-names></name><name><surname>Movassagh</surname><given-names>M.</given-names></name><name><surname>Goh</surname><given-names>H.G.</given-names></name><etal/></person-group> (<year>2010</year>) <article-title>Genome-wide
conserved consensus transcription factor binding motifs are
hyper-methylated</article-title>. <source>BMC Genomics</source>,
<volume>11</volume>, <fpage>519</fpage>.<pub-id pub-id-type="pmid">20875111</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B11">
      <label>11</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medvedeva</surname><given-names>Y.A.</given-names></name><name><surname>Khamis</surname><given-names>A.M.</given-names></name><name><surname>Kulakovskiy</surname><given-names>I.V.</given-names></name><etal/></person-group> (<year>2014</year>) <article-title>Effects of
cytosine methylation on transcription factor binding sites</article-title>.
<source>BMC Genomics</source>, <volume>15</volume>,
<fpage>119</fpage>.<pub-id pub-id-type="pmid">24669864</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B12">
      <label>12</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardo</surname><given-names>L.M.</given-names></name><name><surname>Rizzu</surname><given-names>P.</given-names></name><name><surname>Francescatto</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2013</year>) <article-title>Regional
differences in gene expression and promoter usage in aged human
brains</article-title>. <source>Neurobiol. Aging</source>, <volume>34</volume>,
<fpage>1825</fpage>–<lpage>1836</lpage>.<pub-id pub-id-type="pmid">23428183</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B13">
      <label>13</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohli</surname><given-names>R.M.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group> (<year>2013</year>) <article-title>TET enzymes, TDG and the
dynamics of DNA demethylation</article-title>. <source>Nature</source>,
<volume>502</volume>,
<fpage>472</fpage>–<lpage>479</lpage>.<pub-id pub-id-type="pmid">24153300</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B14">
      <label>14</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>M.</given-names></name><name><surname>Wade</surname><given-names>P.A.</given-names></name></person-group> (<year>2006</year>) <article-title>MBD family proteins:
reading the epigenetic code</article-title>. <source>J. Cell Sci.</source>,
<volume>119</volume>,
<fpage>3033</fpage>–<lpage>3037</lpage>.<pub-id pub-id-type="pmid">16868031</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B15">
      <label>15</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clouaire</surname><given-names>T.</given-names></name><name><surname>Webb</surname><given-names>S.</given-names></name><name><surname>Skene</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2012</year>) <article-title>Cfp1 integrates
both CpG content and gene activity for accurate H3K4me3 deposition in embryonic
stem cells</article-title>. <source>Genes Dev.</source>, <volume>26</volume>,
<fpage>1714</fpage>–<lpage>1728</lpage>.<pub-id pub-id-type="pmid">22855832</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B16">
      <label>16</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luger</surname><given-names>K.</given-names></name><name><surname>Mader</surname><given-names>A.W.</given-names></name><name><surname>Richmond</surname><given-names>R.K.</given-names></name><etal/></person-group> (<year>1997</year>) <article-title>Crystal
structure of the nucleosome core particle at 2.8 A resolution</article-title>.
<source>Nature</source>, <volume>389</volume>,
<fpage>251</fpage>–<lpage>260</lpage>.<pub-id pub-id-type="pmid">9305837</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B17">
      <label>17</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balhorn</surname><given-names>R.</given-names></name></person-group> (<year>2007</year>) <article-title>The protamine family of
sperm nuclear proteins</article-title>. <source>Genome Biol.</source>,
<volume>8</volume>, <fpage>227</fpage>.<pub-id pub-id-type="pmid">17903313</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B18">
      <label>18</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>J.</given-names></name><name><surname>Heard</surname><given-names>E.</given-names></name></person-group> (<year>2009</year>) <article-title>X inactivation and the
complexities of silencing a sex chromosome</article-title>. <source>Curr. Opin.
Cell Biol.</source>, <volume>21</volume>,
<fpage>359</fpage>–<lpage>366</lpage>.<pub-id pub-id-type="pmid">19477626</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B19">
      <label>19</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Attikum</surname><given-names>H.</given-names></name><name><surname>Gasser</surname><given-names>S.M.</given-names></name></person-group> (<year>2009</year>) <article-title>Crosstalk between
histone modifications during the DNA damage response</article-title>.
<source>Trends Cell Biol.</source>, <volume>19</volume>,
<fpage>207</fpage>–<lpage>217</lpage>.<pub-id pub-id-type="pmid">19342239</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B20">
      <label>20</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bannister</surname><given-names>A.J.</given-names></name><name><surname>Kouzarides</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>) <article-title>Regulation of chromatin
by histone modifications</article-title>. <source>Cell Res.</source>,
<volume>21</volume>, <fpage>381</fpage>–<lpage>395</lpage>.<pub-id pub-id-type="pmid">21321607</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B21">
      <label>21</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Q.</given-names></name><name><surname>Wani</surname><given-names>A.A.</given-names></name></person-group> (<year>2010</year>) <article-title>Histone modifications:
crucial elements for damage response and chromatin restoration</article-title>.
<source>J. Cell. Physiol.</source>, <volume>223</volume>,
<fpage>283</fpage>–<lpage>288</lpage>.<pub-id pub-id-type="pmid">20112283</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B22">
      <label>22</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenuwein</surname><given-names>T.</given-names></name><name><surname>Allis</surname><given-names>C.D.</given-names></name></person-group> (<year>2001</year>) <article-title>Translating the histone
code</article-title>. <source>Science</source>, <volume>293</volume>,
<fpage>1074</fpage>–<lpage>1080</lpage>.<pub-id pub-id-type="pmid">11498575</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B23">
      <label>23</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliver</surname><given-names>S.S.</given-names></name><name><surname>Denu</surname><given-names>J.M.</given-names></name></person-group> (<year>2011</year>) <article-title>Dynamic interplay
between histone H3 modifications and protein interpreters: emerging evidence for a
“histone language”</article-title>. <source>Chembiochem</source>,
<volume>12</volume>, <fpage>299</fpage>–<lpage>307</lpage>.<pub-id pub-id-type="pmid">21243717</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B24">
      <label>24</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teif</surname><given-names>V.B.</given-names></name><name><surname>Rippe</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>) <article-title>Predicting nucleosome
positions on the DNA: combining intrinsic sequence preferences and remodeler
activities</article-title>. <source>Nucleic Acids Res.</source>,
<volume>37</volume>,
<fpage>5641</fpage>–<lpage>5655</lpage>.<pub-id pub-id-type="pmid">19625488</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B25">
      <label>25</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgess</surname><given-names>R.J.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name></person-group> (<year>2013</year>) <article-title>Histone chaperones in
nucleosome assembly and human disease</article-title>. <source>Nat. Struct. Mol.
Biol.</source>, <volume>20</volume>,
<fpage>14</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">23288364</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B26">
      <label>26</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>T.</given-names></name><name><surname>Medvedeva</surname><given-names>Y.A.</given-names></name><name><surname>Jia</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2014</year>) <article-title>Promoter
analysis reveals globally differential regulation of human long non- coding RNA
and protein-coding genes</article-title>. <source>PLoS One</source>,
<volume>9</volume>, <fpage>e109443</fpage>.<pub-id pub-id-type="pmid">25275320</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B27">
      <label>27</label>
      <mixed-citation publication-type="journal"><collab>ENCODE</collab> (<year>2012</year>)
<article-title>An integrated encyclopedia of DNA elements in the human
genome</article-title>. <source>Nature</source>, <volume>489</volume>,
<fpage>57</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="pmid">22955616</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B28">
      <label>28</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartwell</surname><given-names>L.H.</given-names></name><name><surname>Hopfield</surname><given-names>J.J.</given-names></name><name><surname>Leibler</surname><given-names>S.</given-names></name><etal/></person-group> (<year>1999</year>) <article-title>From molecular
to modular cell biology</article-title>. <source>Nature</source>,
<volume>402</volume>, <fpage>C47</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">10591225</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B29">
      <label>29</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>E.R.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name></person-group> (<year>2012</year>) <article-title>Epigenetics: the missing
link to understanding beta-cell dysfunction in the pathogenesis of type 2
diabetes</article-title>. <source>Epigenetics</source>, <volume>7</volume>,
<fpage>841</fpage>–<lpage>852</lpage>.<pub-id pub-id-type="pmid">22810088</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B30">
      <label>30</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esteller</surname><given-names>M.</given-names></name><name><surname>Fraga</surname><given-names>M.F.</given-names></name><name><surname>Paz</surname><given-names>M.F.</given-names></name><etal/></person-group> (<year>2002</year>) <article-title>Cancer
epigenetics and methylation</article-title>. <source>Science</source>,
<volume>297</volume>, <fpage>1807</fpage>–<lpage>1808</lpage>;
<comment>discussion 1807–1808</comment>.<pub-id pub-id-type="pmid">12229925</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B31">
      <label>31</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwok</surname><given-names>J.B.</given-names></name></person-group> (<year>2010</year>) <article-title>Role of epigenetics in
Alzheimer's and Parkinson's disease</article-title>. <source>Epigenomics</source>,
<volume>2</volume>, <fpage>671</fpage>–<lpage>682</lpage>.<pub-id pub-id-type="pmid">22122050</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B32">
      <label>32</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helin</surname><given-names>K.</given-names></name><name><surname>Dhanak</surname><given-names>D.</given-names></name></person-group> (<year>2013</year>) <article-title>Chromatin proteins and
modifications as drug targets</article-title>. <source>Nature</source>,
<volume>502</volume>,
<fpage>480</fpage>–<lpage>488</lpage>.<pub-id pub-id-type="pmid">24153301</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B33">
      <label>33</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grunau</surname><given-names>C.</given-names></name><name><surname>Renault</surname><given-names>E.</given-names></name><name><surname>Rosenthal</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2001</year>) <article-title>MethDB–a
public database for DNA methylation data</article-title>. <source>Nucleic Acids
Res.</source>, <volume>29</volume>,
<fpage>270</fpage>–<lpage>274</lpage>.<pub-id pub-id-type="pmid">11125109</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B34">
      <label>34</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amoreira</surname><given-names>C.</given-names></name><name><surname>Hindermann</surname><given-names>W.</given-names></name><name><surname>Grunau</surname><given-names>C.</given-names></name></person-group> (<year>2003</year>) <article-title>An improved version of
the DNA Methylation database (MethDB)</article-title>. <source>Nucleic Acids
Res.</source>, <volume>31</volume>,
<fpage>75</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">12519951</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B35">
      <label>35</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hackenberg</surname><given-names>M.</given-names></name><name><surname>Barturen</surname><given-names>G.</given-names></name><name><surname>Oliver</surname><given-names>J.L.</given-names></name></person-group> (<year>2011</year>) <article-title>NGSmethDB: a database
for next-generation sequencing single-cytosine-resolution DNA methylation
data</article-title>. <source>Nucleic Acids Res.</source>, <volume>39</volume>,
<fpage>D75</fpage>–<lpage>79</lpage>.<pub-id pub-id-type="pmid">20965971</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B36">
      <label>36</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>D.</given-names></name><name><surname>Sun</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2015</year>) <article-title>MethBank: a
database integrating next-generation sequencing single-base-resolution DNA
methylation programming data</article-title>. <source>Nucleic Acids Res</source>.,
<volume>43</volume>, <fpage>D54</fpage>–<lpage>58</lpage>.<pub-id pub-id-type="pmid">25294826</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B37">
      <label>37</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W.Y.</given-names></name><name><surname>Hsu</surname><given-names>S.D.</given-names></name><name><surname>Huang</surname><given-names>H.Y.</given-names></name><etal/></person-group> (<year>2015</year>) <article-title>MethHC: a
database of DNA methylation and gene expression in human cancer</article-title>.
<source>Nucleic Acids Res</source>., <volume>43</volume>,
<fpage>D856</fpage>–<lpage>861</lpage>.<pub-id pub-id-type="pmid">25398901</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B38">
      <label>38</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Chang</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2008</year>) <article-title>MethyCancer: the
database of human DNA methylation and cancer</article-title>. <source>Nucleic
Acids Res</source>, <volume>36</volume>,
<fpage>D836</fpage>–<lpage>841</lpage>.<pub-id pub-id-type="pmid">17890243</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B39">
      <label>39</label>
      <mixed-citation publication-type="journal"><collab>Cancer Genome Atlas Research
Network</collab> (<year>2008</year>) <article-title>Comprehensive genomic
characterization defines human glioblastoma genes and core
pathways</article-title>. <source>Nature</source>, <volume>455</volume>,
<fpage>1061</fpage>–<lpage>1068</lpage>.<pub-id pub-id-type="pmid">18772890</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B40">
      <label>40</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Lv</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2010</year>) <article-title>HHMD: the human
histone modification database</article-title>. <source>Nucleic Acids
Res.</source>, <volume>38</volume>,
<fpage>D149</fpage>–<lpage>154</lpage>.<pub-id pub-id-type="pmid">19892823</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B41">
      <label>41</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marino-Ramirez</surname><given-names>L.</given-names></name><name><surname>Levine</surname><given-names>K.M.</given-names></name><name><surname>Morales</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2011</year>) <article-title>The Histone
Database: an integrated resource for histones and histone fold-containing
proteins</article-title>. <source>Database</source>, <volume>2011</volume>,
<fpage>bar048</fpage>.<pub-id pub-id-type="pmid">22025671</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B42">
      <label>42</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khare</surname><given-names>S.P.</given-names></name><name><surname>Habib</surname><given-names>F.</given-names></name><name><surname>Sharma</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2012</year>) <article-title>HIstome–a
relational knowledgebase of human histone proteins and histone modifying
enzymes</article-title>. <source>Nucleic Acids Res.</source>, <volume>40</volume>,
<fpage>D337</fpage>–<lpage>342</lpage>.<pub-id pub-id-type="pmid">22140112</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B43">
      <label>43</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gendler</surname><given-names>K.</given-names></name><name><surname>Paulsen</surname><given-names>T.</given-names></name><name><surname>Napoli</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>) <article-title>ChromDB: the chromatin
database</article-title>. <source>Nucleic Acids Res.</source>,
<volume>36</volume>, <fpage>D298</fpage>–<lpage>302</lpage>.<pub-id pub-id-type="pmid">17942414</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B44">
      <label>44</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shipra</surname><given-names>A.</given-names></name><name><surname>Chetan</surname><given-names>K.</given-names></name><name><surname>Rao</surname><given-names>M.R.</given-names></name></person-group> (<year>2006</year>) <article-title>CREMOFAC–a
database of chromatin remodeling factors</article-title>.
<source>Bioinformatics</source>, <volume>22</volume>,
<fpage>2940</fpage>–<lpage>2944</lpage>.<pub-id pub-id-type="pmid">17021159</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B45">
      <label>45</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2014</year>) <article-title>CR Cistrome: a
ChIP-Seq database for chromatin regulators and histone modification linkages in
human and mouse</article-title>. <source>Nucleic Acids Res.</source>,
<volume>42</volume>,
<fpage>D450</fpage>–<lpage>458</lpage>.<pub-id pub-id-type="pmid">24253304</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B46">
      <label>46</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2013</year>) <article-title>PEpiD: a
prostate epigenetic database in mammals</article-title>. <source>PLoS
One</source>, <volume>8</volume>, <fpage>e64289</fpage>.<pub-id pub-id-type="pmid">23696878</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B47">
      <label>47</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>S.Y.</given-names></name><name><surname>Chai</surname><given-names>J.C.</given-names></name><name><surname>Park</surname><given-names>S.J.</given-names></name><etal/></person-group> (<year>2013</year>) <article-title>EPITRANS: a
database that integrates epigenome and transcriptome data</article-title>.
<source>Mol. Cells</source>, <volume>36</volume>,
<fpage>472</fpage>–<lpage>475</lpage>.<pub-id pub-id-type="pmid">24213601</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B48">
      <label>48</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fingerman</surname><given-names>I.M.</given-names></name><name><surname>McDaniel</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2011</year>) <article-title>NCBI
Epigenomics: a new public resource for exploring epigenomic data
sets</article-title>. <source>Nucleic Acids Res.</source>, <volume>39</volume>,
<fpage>D908</fpage>–<lpage>912</lpage>.<pub-id pub-id-type="pmid">21075792</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B49">
      <label>49</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fingerman</surname><given-names>I.M.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Ratzat</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2013</year>) <article-title>NCBI
Epigenomics: what's new for 2013</article-title>. <source>Nucleic Acids
Res.</source>, <volume>41</volume>,
<fpage>D221</fpage>–<lpage>225</lpage>.<pub-id pub-id-type="pmid">23193265</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B50">
      <label>50</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chadwick</surname><given-names>L.H.</given-names></name></person-group> (<year>2012</year>) <article-title>The NIH Roadmap
Epigenomics Program data resource</article-title>. <source>Epigenomics</source>,
<volume>4</volume>, <fpage>317</fpage>–<lpage>324</lpage>.<pub-id pub-id-type="pmid">22690667</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B51">
      <label>51</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meldal</surname><given-names>B.H.</given-names></name><name><surname>Forner-Martinez</surname><given-names>O.</given-names></name><name><surname>Costanzo</surname><given-names>M.C.</given-names></name><etal/></person-group> (<year>2015</year>) <article-title>The complex
portal—an encyclopaedia of macromolecular complexes</article-title>.
<source>Nucleic Acids Res.</source>, <volume>43</volume>,
<fpage>D479</fpage>–<lpage>484</lpage>.<pub-id pub-id-type="pmid">25313161</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B52">
      <label>52</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orchard</surname><given-names>S.</given-names></name><name><surname>Ammari</surname><given-names>M.</given-names></name><name><surname>Aranda</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2014</year>) <article-title>The MIntAct
project—IntAct as a common curation platform for 11 molecular interaction
databases</article-title>. <source>Nucleic Acids Res.</source>,
<volume>42</volume>,
<fpage>D358</fpage>–<lpage>363</lpage>.<pub-id pub-id-type="pmid">24234451</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B53">
      <label>53</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Bonasio</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2012</year>) <article-title>PCGF homologs,
CBX proteins, and RYBP define functionally distinct PRC1 family
complexes</article-title>. <source>Mol. Cell</source>, <volume>45</volume>,
<fpage>344</fpage>–<lpage>356</lpage>.<pub-id pub-id-type="pmid">22325352</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B54">
      <label>54</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuettengruber</surname><given-names>B.</given-names></name><name><surname>Martinez</surname><given-names>A.M.</given-names></name><name><surname>Iovino</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2011</year>) <article-title>Trithorax group
proteins: switching genes on and keeping them active</article-title>. <source>Nat.
Rev. Mol. Cell Biol.</source>, <volume>12</volume>,
<fpage>799</fpage>–<lpage>814</lpage>.<pub-id pub-id-type="pmid">22108599</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B55">
      <label>55</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laugesen</surname><given-names>A.</given-names></name><name><surname>Helin</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>) <article-title>Chromatin repressive
complexes in stem cells, development, and cancer</article-title>. <source>Cell
Stem Cell</source>, <volume>14</volume>,
<fpage>735</fpage>–<lpage>751</lpage>.<pub-id pub-id-type="pmid">24905164</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B56">
      <label>56</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meier</surname><given-names>K.</given-names></name><name><surname>Brehm</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>) <article-title>Chromatin regulation:
How complex does it get?</article-title>
<source>Epigenetics</source>, <volume>9</volume>,
<fpage>1485</fpage>–<lpage>1495</lpage>.<pub-id pub-id-type="pmid">25482055</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B57">
      <label>57</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Workman</surname><given-names>J.L.</given-names></name><etal/></person-group> (<year>2011</year>) <article-title>Readers of
histone modifications</article-title>. <source>Cell Res.</source>,
<volume>21</volume>, <fpage>564</fpage>–<lpage>578</lpage>.<pub-id pub-id-type="pmid">21423274</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B58">
      <label>58</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allis</surname><given-names>C.D.</given-names></name><name><surname>Berger</surname><given-names>S.L.</given-names></name><name><surname>Cote</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2007</year>) <article-title>New nomenclature
for chromatin-modifying enzymes</article-title>. <source>Cell</source>,
<volume>131</volume>,
<fpage>633</fpage>–<lpage>636</lpage>.<pub-id pub-id-type="pmid">18022353</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B59">
      <label>59</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname><given-names>M.K.</given-names></name><name><surname>Zimmer</surname><given-names>B.</given-names></name><name><surname>Poltl</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2012</year>) <article-title>Extensive
transcriptional regulation of chromatin modifiers during human
neurodevelopment</article-title>. <source>PLoS One</source>, <volume>7</volume>,
<fpage>e36708</fpage>.<pub-id pub-id-type="pmid">22590590</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B60">
      <label>60</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plass</surname><given-names>C.</given-names></name><name><surname>Pfister</surname><given-names>S.M.</given-names></name><name><surname>Lindroth</surname><given-names>A.M.</given-names></name><etal/></person-group> (<year>2013</year>) <article-title>Mutations in
regulators of the epigenome and their connections to global chromatin patterns in
cancer</article-title>. <source>Nat. Rev. Genet.</source>, <volume>14</volume>,
<fpage>765</fpage>–<lpage>780</lpage>.<pub-id pub-id-type="pmid">24105274</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B61">
      <label>61</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forrest</surname><given-names>A.R.</given-names></name><name><surname>Kawaji</surname><given-names>H.</given-names></name><name><surname>Rehli</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2014</year>) <article-title>A promoter-level
mammalian expression atlas</article-title>. <source>Nature</source>,
<volume>507</volume>,
<fpage>462</fpage>–<lpage>470</lpage>.<pub-id pub-id-type="pmid">24670764</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B62">
      <label>62</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulakovskiy</surname><given-names>I.V.</given-names></name><name><surname>Medvedeva</surname><given-names>Y.A.</given-names></name><name><surname>Schaefer</surname><given-names>U.</given-names></name><etal/></person-group> (<year>2013</year>) <article-title>HOCOMOCO: a
comprehensive collection of human transcription factor binding sites
models</article-title>. <source>Nucleic Acids Res.</source>, <volume>41</volume>,
<fpage>D195</fpage>–<lpage>202</lpage>.<pub-id pub-id-type="pmid">23175603</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B63">
      <label>63</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dillon</surname><given-names>S.C.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Trievel</surname><given-names>R.C.</given-names></name><etal/></person-group> (<year>2005</year>) <article-title>The SET-domain
protein superfamily: protein lysine methyltransferases</article-title>.
<source>Genome Biol.</source>, <volume>6</volume>,
<fpage>227</fpage>.<pub-id pub-id-type="pmid">16086857</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B64">
      <label>64</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukada</surname><given-names>Y.</given-names></name><name><surname>Fang</surname><given-names>J.</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2006</year>) <article-title>Histone
demethylation by a family of JmjC domain-containing proteins</article-title>.
<source>Nature</source>, <volume>439</volume>,
<fpage>811</fpage>–<lpage>816</lpage>.<pub-id pub-id-type="pmid">16362057</pub-id></mixed-citation>
    </ref>
    <ref id="bav067-B65">
      <label>65</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Serna</surname><given-names>I.L.</given-names></name><name><surname>Ohkawa</surname><given-names>Y.</given-names></name><name><surname>Imbalzano</surname><given-names>A.N.</given-names></name></person-group> (<year>2006</year>) <article-title>Chromatin remodelling in
mammalian differentiation: lessons from ATP-dependent remodellers</article-title>.
<source>Nat. Rev. Genet.</source>, <volume>7</volume>,
<fpage>461</fpage>–<lpage>473</lpage>.<pub-id pub-id-type="pmid">16708073</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
